Catalyst
Slingshot members are tracking this event:
European Commission Announces Renewal of Marketing Authorization for PTC Therapeutics' (PTCT) Translarna in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) in Ambulatory Patients at Least Five Years Old
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PTCT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 11, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Renewal, Marketing Authorization, Translarna, Nonsense Mutation, Duchenne Muscular Dystrophy, Ambulatory Patients, Five Years Old, Chmp
